MariMed Inc.
MRMD · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.9% | 4.4% | -2.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 40.1% | 40.5% | 39.9% | 32.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 10.9% | 10.8% | 5.1% | 4.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7.2% | -3.2% | -14.4% | -21% |
| EPS Diluted | -0.01 | -0.003 | -0.014 | -0.022 |
| % Growth | -203% | 76.9% | 33.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |